Wells Fargo & Company Enzo Biochem Inc Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$3.78 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$1.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.37 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.08 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$974,1699.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $35.6M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...